Global Stent Grafts Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

The global stent grafts market is primarily segmented by product, with the key categories including abdominal aortic aneurysm (AAA) stent grafts, thoracic aortic aneurysm (TAA) stent grafts, and peripheral artery disease (PAD) stent grafts. AAA stent grafts are the most commonly used for treating abdominal aortic aneurysms, while TAA stent grafts are specifically designed for managing thoracic aortic aneurysms. PAD stent grafts are employed to treat peripheral artery disease, particularly in the femoral, iliac, and popliteal arteries. The increasing prevalence of cardiovascular diseases globally drives the demand for these specialized stent grafts.

In terms of application, stent grafts are primarily used for treating vascular diseases, aortic aneurysms, and arterial blockages. The most prominent applications involve the treatment of aneurysms, where stent grafts are used to reinforce weakened arterial walls and prevent rupture. Additionally, stent grafts are used in minimally invasive procedures for managing conditions like PAD, offering a less invasive alternative to traditional surgery. The rising incidence of vascular diseases, along with growing awareness of minimally invasive treatment options, is driving the growth of the market.

Geographically, the global stent grafts market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America holds a significant market share, driven by advancements in healthcare infrastructure, the availability of cutting-edge medical technologies, and high adoption rates of stent graft procedures. Europe also contributes significantly due to favorable reimbursement policies and well-established medical devices regulatory frameworks. The Asia Pacific region is expected to experience substantial growth due to the increasing prevalence of cardiovascular diseases and expanding healthcare access in emerging economies.

Global Stent Grafts Segment Analysis

In this report, the global stent grafts market has been segmented by product , Application and geography.

Global Stent Grafts Market, Segmentation by Product

The Global Stent Grafts Market has been segmented by Product into Coronary stent grafts and Peripheral stent grafts.

Coronary stent grafts and Peripheral stent grafts. Coronary stent grafts are specifically designed to address blockages or narrowings in the coronary arteries, providing a critical solution for patients suffering from coronary artery disease. These stent grafts play a crucial role in restoring blood flow to the heart muscle, thereby reducing the risk of heart attacks and other cardiovascular complications. On the other hand, Peripheral stent grafts are tailored to treat vascular conditions outside the coronary arteries, targeting areas such as the carotid, iliac, femoral, and renal arteries. They are instrumental in managing peripheral artery disease and preventing related complications such as limb ischemia and amputation.

This segmentation facilitates a focused analysis of the diverse applications and market dynamics associated with coronary and peripheral stent grafts. It allows stakeholders to gain insights into the specific challenges and opportunities within each segment, guiding strategic decisions related to product development, marketing strategies, and geographical expansion. Additionally, understanding the unique needs of patients and healthcare providers in both coronary and peripheral vascular interventions is essential for driving innovation and improving patient outcomes in the global stent grafts market.

Global Stent Grafts Market, Segmentation by Application

The Global Stent Grafts Market has been segmented by Application into EVAR, FEVAR, chimney, others

These applications include Endovascular Aneurysm Repair (EVAR), Fenestrated Endovascular Aneurysm Repair (FEVAR), chimney procedures, and others. EVAR involves the minimally invasive repair of abdominal aortic aneurysms using stent grafts, offering patients a safer alternative to traditional open surgery. FEVAR expands on EVAR by addressing complex anatomies, utilizing stent grafts with customized fenestrations or branches to accommodate renal or visceral arteries.

Chimney procedures, also known as parallel grafts, involve deploying additional stent grafts alongside the main stent graft to maintain blood flow to vital branches or arteries. This technique is particularly useful in cases where the main artery branches into smaller vessels. The segmentation into these specific applications enables a nuanced understanding of the market landscape, allowing stakeholders to identify key growth opportunities and tailor their strategies to meet the evolving needs of patients and healthcare providers. As the demand for minimally invasive endovascular procedures continues to rise, advancements in stent graft technologies and techniques are expected to drive further innovation and expansion within the global stent grafts market.

Global Stent Grafts Market, Segmentation by Geography

In this report, the Global Stent Grafts Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.

Global Stent Grafts Market Share (%), by Geographical Region, 2024

North America, Europe, Asia Pacific, Middle East and Africa, and Latin America. Each of these regions represents a distinct market landscape characterized by unique regulatory frameworks, healthcare infrastructure, and patient demographics.

North America, comprising the United States and Canada, stands as a major market for stent grafts, driven by a robust healthcare system, high prevalence of cardiovascular diseases, and advanced medical technologies. Europe follows closely, with countries like Germany, the United Kingdom, and France contributing significantly to market growth due to increasing adoption of minimally invasive procedures and rising geriatric population. In the Asia Pacific region, countries such as China, Japan, and India are witnessing rapid growth in the stent grafts market, fueled by improving healthcare infrastructure, rising disposable incomes, and a growing awareness of cardiovascular health. The Middle East and Africa, along with Latin America, present emerging markets with expanding healthcare access and increasing investments in medical technologies. Understanding the dynamics within each of these regions is essential for market players to effectively navigate opportunities and challenges, tailor their strategies, and capitalize on the evolving landscape of the Global Stent Grafts Market.

This report provides an in depth analysis of various factors that impact the dynamics of Global Stent Grafts Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.

Drivers, Restraints and Opportunity Analysis

Drivers :

• Rising prevalence of aortic diseases
• Technological advancements

• Growing adoption of minimally invasive procedures - The global stent grafts market is experiencing a notable surge in adoption, driven primarily by the growing preference for minimally invasive procedures. Minimally invasive techniques offer several advantages over traditional open surgeries, including reduced recovery times, shorter hospital stays, and lower risks of complications. Stent grafts, in particular, have emerged as a cornerstone of minimally invasive endovascular interventions, enabling physicians to treat a wide range of vascular conditions with precision and efficacy.

  The shift towards minimally invasive procedures is fueled by increasing patient demand for treatments that minimize discomfort and downtime. Moreover, advancements in stent graft technology have expanded the scope of endovascular interventions, allowing for the treatment of complex anatomies and high-risk patient populations. As healthcare providers continue to recognize the benefits of minimally invasive approaches, the global stent grafts market is poised for sustained growth, with innovation driving further improvements in patient outcomes and procedural efficiency.

Restraints :

• High cost of procedures
• Reimbursement concerns

• Stringent regulatory approvals - The global stent grafts market is subject to stringent regulatory approvals imposed by regulatory authorities worldwide. These regulations are in place to ensure the safety, efficacy, and quality of stent graft products before they can be introduced to the market and used in clinical practice. Companies operating in this market must adhere to rigorous standards and undergo thorough testing and clinical trials to demonstrate the safety and effectiveness of their products. Regulatory requirements vary from country to country but generally involve comprehensive documentation of product design, manufacturing processes, preclinical testing, and clinical trial data.

  Compliance with regulatory approvals is essential for market access and commercial success. Failure to meet regulatory standards can result in delays in product launch, additional testing requirements, or even rejection of market authorization, leading to significant financial losses for companies. Therefore, manufacturers invest substantial resources in navigating the regulatory landscape, collaborating closely with regulatory agencies to ensure compliance and expedite the approval process. Despite the challenges posed by regulatory requirements, adherence to these standards ultimately promotes patient safety and fosters trust in the global stent grafts market.

Opportunities :

• Development of new materials and technologies

• Focus on ambulatory surgical centers - The Global Stent Grafts Market has recently seen a notable focus on ambulatory surgical centers (ASCs), reflecting a growing trend towards outpatient procedures for vascular interventions. ASCs offer a convenient and cost-effective alternative to traditional hospital settings, providing patients with access to specialized care in a more comfortable environment. With advancements in stent graft technology and techniques, many endovascular procedures previously performed in hospitals can now be safely and effectively conducted in ASCs, including certain types of stent graft placements for aortic aneurysms and peripheral artery disease.

  This shift towards ASCs is driven by several factors, including the desire to reduce healthcare costs, minimize hospital stays, and enhance patient satisfaction. ASCs are well-positioned to capitalize on the increasing demand for minimally invasive procedures, as they offer streamlined workflows, shorter wait times, and personalized care. Moreover, the COVID-19 pandemic has accelerated the adoption of ASCs for elective surgeries, as they provide a safer environment with lower risk of exposure to infectious diseases. As such, the focus on ambulatory surgical centers in the global stent grafts market is expected to continue to grow, presenting opportunities for manufacturers, healthcare providers, and patients alike.

Key players in Global Stent Grafts Market include

• Becton
• Dickinson and Co
• Cardinal Health Inc
• Cook Group Inc
• CryoLife Inc
• Endologix Inc
• Endospan Ltd
• Medtronic Plc
• MicroPort Scientific Corp
• Terumo Corp
• W. L. Gore & Associates Inc

In this report, the profile of each market player provides following information:

• Company Overview and Product Portfolio
• Key Developments
• Financial Overview
• Strategies
• Company SWOT Analysis